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Genetic Deletion of Uncoupling Protein 3 Exaggerates Apoptotic Cell
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Background-—Uncoupling protein 3 (ucp3) is a member of the mitochondrial anion carrier superfamily of proteins uncoupling
mitochondrial respiration. In this study, we investigated the effects of ucp3 genetic deletion on mitochondrial function and cell
survival under low oxygen conditions in vitro and in vivo.
Methods and Results-—To test the effects of ucp3 deletion in vitro, murine embryonic fibroblasts and adult cardiomyocytes were
isolated from wild-type (WT, n=67) and ucp3 knockout mice (ucp3/, n=70). To test the effects of ucp3 genetic deletion in vivo,
myocardial infarction (MI) was induced by permanent coronary artery ligation in WT and ucp3/mice. Compared with WT, ucp3/
murine embryonic fibroblasts and cardiomyocytes exhibited mitochondrial dysfunction and increased mitochondrial reactive
oxygen species generation and apoptotic cell death under hypoxic conditions in vitro (terminal deoxynucleotidyl transferase-dUTP
nick end labeling–positive nuclei: WT hypoxia, 70.31.2%; ucp3/ hypoxia, 85.30.9%; P<0.05). After MI, despite similar areas
at risk in the 2 groups, ucp3/ hearts demonstrated a significantly larger infarct size compared with WT (infarct area/area at risk:
WT, 48.23.7%; ucp3/, 65.02.9%; P<0.05). Eight weeks after MI, cardiac function was significantly decreased in ucp3/
mice compared with WT (fractional shortening: WT MI, 42.73.1%; ucp3/ MI, 24.42.9; P<0.05), and this was associated with
heightened apoptotic cell death (terminal deoxynucleotidyl transferase-dUTP nick end labeling–positive nuclei: WT MI, 0.70.04%;
ucp3/ MI, 1.10.09%, P<0.05).
Conclusions-—Our data indicate that ucp3 levels regulate reactive oxygen species levels and cell survival during hypoxia,
modulating infarct size in the ischemic heart. ( J Am Heart Assoc. 2013;2:e000086 doi: 10.1161/JAHA.113.000086)
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H eart failure (HF) represents one of the main causes ofdeath and mortality in the Western countries.1 Coro-
nary artery disease and arterial hypertension represent the
leading causes of HF.2
Oxidative stress mediated by reactive oxygen species
(ROS) plays a striking role in cardiomyocyte (CM) death and in
the pathogenesis of HF, particularly after myocardial infarc-
tion (MI).3,4 Although antioxidants attenuate cardiac remod-
eling in different experimental models of MI,5 and several
drugs that have beneficial effects on ventricular function and
prognosis also have some antioxidant effects,6,7 clinical trials
have not confirmed the beneficial effects of different antiox-
idants on postischemic cardiac remodeling.8,9
Increased ROS production may contribute to the develop-
ment of cardiac dysfunction with different mechanisms,
including myocyte loss via apoptosis or other cell death
mechanisms.10–12 Several sources of increased ROS
production have been identified in the overloaded heart,13
with the mitochondria being one of the major components.13
Mitochondrial ROS production can be controlled by a family of
uncoupling proteins (ucps) that catalyze a regulated proton
leak across the inner mitochondrial membrane, diverting free
energy from the ATP synthesis chain to the production of
heat,14 and thus reducing ROS production.15
So far, 5 ucp isoforms have been identified in mammals,
named ucp1 to 5 in the order of their discovery16; ucp1 is the
most extensively characterized member of the family and is
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exclusively expressed in brown adipose tissue.17,18 In contrast,
ucp2 and ucp3 are expressed primarily in skeletal muscle and in
the heart, where their role is still not completely defined.
Coronary artery ligation and in vitro hypoxia are potent inducers
of both ucp2 and ucp3 messenger RNA (mRNA) and protein
levels, suggesting that these proteins might play a relevant role
in the regulation of cardiac tolerance to ischemia. Indeed,
recent studies have shown that ucp2 or ucp3 activation might
mitigate ROS production14,16,19,20 and CM death.21 In partic-
ular, it has been proposed that enhanced ucp2 expression
might represent an important adaptation in the chronically
ischemic myocardial tissue.22 In contrast, ucp3 expression is
significantly reduced in samples from failing human hearts, and
mechanical unloading of the left ventricle has been shown to
reverse these changes.23
In the present study, we tested whether ucp3 deletion
might affect mitochondrial function, ROS production, and cell
survival in vitro under normal or hypoxic conditions and in the
heart undergoing chronic HF after permanent coronary artery
ligation. Our study shows that ucp3 genetic deletion promotes
mitochondrial dysfunction and increases ROS production and
apoptotic cell death during in vitro hypoxia and in the
ischemic heart, suggesting that ucp3 might represent a novel




All experiments involving animals conformed to the “Guide for
the Care and Use of Laboratory Animals” published by the US
National Institutes of Health (NIH PublicationNo. 85-23, revised
1996) and were approved by the animal welfare regulation of
University Federico II of Naples, Italy. Mice were purchased
from the Jackson Laboratory (genetic background—Strain:
129S4/SvJae). The ucp3/ mice were obtained as previously
described.24 Male adult ucp3/ (aged 8 to 9 weeks, N=70)
and wild-type (WT) mice (aged 8 to 9 weeks, N=67) were
included in the study and maintained under identical conditions
of temperature (211°C), humidity (605%), and light–dark
cycle and had free access to normal mouse chow.
Mouse Model of MI and Infarct Size
Determination
MI was induced in ucp3/ (n=30) and WT mice (n=28) by
permanent coronary artery ligation as previously described.25
Sham-operated animals underwent the same procedure
without ligation of the left coronary artery at the same time
(sham: WT, n=11; ucp3/, n=12). An additional group of
mice underwent systemic delivery of the antioxidant
a-tocopherol 12 hours before, 75 minutes before, and
12 hours after MI (MI+a-tocopherol, 150 mg/kg IV, n=5).
To determine infarct size, some animals were anesthetized
24 hours (WT, n=7; ucp3/, n=7) after coronary artery
ligation, and the hearts were perfused with 1% Evans blue to
determine the area at risk (AAR) and then removed, as
previously described.26 Each heart was sliced horizontally to
yield 4 slices, and the slices were incubated in 1% triphenyl-
tetrazolium chloride (Sigma-Aldrich) prepared with Tris
200 mmol/L buffer (pH 7.8) for 15 minutes at 37°C. With
this procedure, viable nonischemic myocardium stains blue,
ischemic but still viable myocardium stains red, whereas the
necrotic myocardium does not stain and appears pale white.
The infarct area (IA, white) and the AAR (red and white) from
each section were measured using an image analyzer (ImageJ
software). Ratios of AAR/left ventricular (LV) area and IA/AAR
were calculated and expressed as a percentage. Eight weeks
after coronary artery ligation, in additional mice the hearts
were arrested in diastole with a 300-lL injection of saturated
KCl solution in the right atrium, and the hearts were flash-
frozen in liquid nitrogen to perform molecular analyses or fixed
in 4% formaldehyde to perform histological analyses (see later).
Mouse Model of Myocardial Ischemia–
Reperfusion Injury
Myocardial ischemia–reperfusion injurywas inducedinucp3/
(n=6) and WT mice (n=6) as previously described.27 Briefly,
ucp3/ mice and their WT littermates were anesthetized
with an intramuscular injection of ketamine 100 mg/kg and
xylazine 2.5 mg/kg. After intubation (polyethylene-60 tubing),
the animals were ventilated with a stroke rate of 130/min and
a tidal volume of 1 mL. A midline thoracotomy and pericar-
diotomy were performed. The left anterior descending coro-
nary artery was occluded 2 to 3 mm distal to the tip of the left
auricle using a 7.0 silk suture and a small tube to form a snare
for 30 minutes. Hearts were then reperfused for 120 min-
utes. At the end of the protocol, the hearts were freshly put
on mitochondria isolation buffer (in mmol/L: sucrose 70,
mannitol 220, Tris 20 (pH 8.5, EDTA 1, pH 7.4) to perform
mitochondrial respiration experiments (see later).
Morphological Studies
Mouse heart specimens fixed in 4% formaldehyde were
embedded in paraffin, and after deparaffinization and rehy-
dration, 4-lm-thick sections were prepared, mounted on glass
slides, and stained with hematoxylin–eosin or Masson’s
trichrome as previously described.28 To determine infarct
size, total LV epicardial and endocardial circumferences and
epicardial and endocardial borders of infarcted regions were
measured and averaged using computer-assisted image
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analysis software (ImageJ software). To quantify myocardial
capillary density, lectin staining was used to specifically stain
endothelial cells, as previously described.29
The DNA nicks were determined with the use of an in situ
Apoptosis Detection kit or ApopTag Fluorescein Direct in Situ
Apoptosis Detection kit (Chemicon) according to the manu-
facturer’s instructions as previously described both in vivo
and in cultured cells (see later).30,31 Terminal deoxynucleot-
idyl transferase-dUTP nick end labeling (TUNEL) staining was
visualized by specific green fluorescence and nuclei by
4′-6-diamidino-2-phenylindole (DAPI). The number of TUNEL-
positive CM nuclei was counted, and data were normalized
per total nuclei identified by DAPI staining in the same
sections (n=7 or 8 animals/group). Equal numbers of cells
were analyzed per group, and statistical analysis was
performed on myocyte groups by 2-way ANOVA.
Transthoracic Echocardiography
Cardiac function was noninvasively monitored by transtho-
racic echocardiography using the Vevo 770 high-resolution
imaging system (VisualSonics) before the surgery and right
before termination, 8 weeks after surgery, as previously
described.32 Briefly, the mice were anesthetized with an
intramuscular injection of ketamine 100 mg/kg and xylazine
2.5 mg/kg, and echocardiograms were performed with a 30-
MHz RMV-707B scanning head.
Positron Emission Tomography
The accuracy and reproducibility of high-resolution positron
emission tomography/computed tomography with 2-deoxy-2
[18F]fluoro-D-glucose (18F-FDG) for noninvasive quantification
of myocardial infarct size in mice have been recently
documented.33 Eight weeks after surgical coronary ligation,
18F-FDG in 100 mL of 0.9% saline was injected intravenously,
to obtain images of mouse hearts, 1 hour before each scan.
After the administration of ketamine 100 mg/kg and xylazine
2.5 mg/kg, the mouse was placed on a heating pad to
maintain a body temperature within the normal range.
List-mode data were acquired for 15 minutes and subse-
quently reconstructed into a single image volume of
110960960 mm3. The images were obtained using an
eXplore Vista computed tomograph (General Electric). The
animals had unrestricted access to water and their normal
food before scanning.
Cell Culture and In Vitro Hypoxia
Mouse embryonic fibroblasts (MEFs) and adult mouse CMs
were obtained from WT and ucp3/ mice.
For MEF isolation, the embryos were taken from pregnant
females at days 13 and 14 of gestation. Immediately after
the levy, embryos were transferred in new sterile plates
containing PBS–penicillin/streptomycin 2%. After removal of
the head and the liver, embryos were repeatedly washed in a
sterile solution made of PBS–penicillin/streptomycin 2% and
then transferred in a 1-mL syringe containing trypsin-EDTA.
Hence, embryos were mechanically homogenized and the
product was incubated at 37°C for 5 minutes. The isolated
cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 0.1% FBS, L-glutamine 200 mg/
mL, penicillin 100 units/mL, streptomycin 100 lg/mL, and
0.01% nonessential amino acids.
CMs were isolated and cultured using a modification of the
collagenase dissociation method described by Zhou et al.34
Briefly, mice were treated with heparin (50 units) and
anesthetized with an intramuscular injection of ketamine
100 mg/kg and xylazine 2.5 mg/kg. The heart was quickly
excised, and the aorta was cannulated for retrograde
perfusion in a Langendorff apparatus at a constant flow rate
of 3 mL/min at 37°C. The heart was perfused for 9 to
10 minutes with isolation buffer (NaCl 120 mmol/L, KCl
5.4 mmol/L, MgSO4 1.2 mmol/L, NaH2PO4 1.2 mmol/L,
glucose 5.6 mmol/L, NaHCO3 5 mmol/L, HEPES 10 mmol/L,
CaCl2 50 lmol/L, 2,3-butanedione monoxime [BDM]
10 mmol/L, and taurine 5 mmol/L), followed by digestion
for 9 minutes with collagenase II (1.5 mg/mL; Worthington)
in isolation buffer. After digestion, the soft and flaccid heart
was removed, and the myocytes were suspended in
isolation buffer. A series of 4 centrifugations (40g91 minute)
and resuspensions were used for stepwiseCa2+ reintroduction
from 50 lmol/L to 1.0 mmol/L, which was the final medium
Ca2+ concentration. Isolated CMs were plated for 2 hours
onto 35- and 60-mm tissue culture dishes coated with
laminin 10 lg/mL. The cells were suspended in minimum
essential medium (MEM) with Hanks’ buffered salt solu-
tion (HBSS), penicillin 10 lg/mL, vitamin B12 1.5 lmol/L,
and BDM 10 mmol/L. After this period of attachment,
the medium was changed to MEM-HBSS containing penicil-
lin 10 lg/mL, vitamin B12 1.5 lmol/L, and BDM 1 mmol/L
and was incubated overnight at 37°C in a humidified
atmosphere of 1% CO2 and air. The culture protocol yielded
an average of 80% rod-shaped myocytes at a plating density
of 50 cells/mm2 that were viable at pH 7.2 for 48 hours.
Experiments were performed the day after isolation and
culture.
Hypoxia (2% O2) was induced when MEFs and CMs were
at 0.85 confluence. After being washed 3 times, cultures
were transferred to a 37°C incubator within an hypoxic
chamber (93% nitrogen–5% CO2–2% oxygen), and DMEM
was replaced with a saline buffer that was prebubbled for
5 minutes with the same gas mix to provide a media PO2
(14.7 mm Hg) equivalent to that in the ambient air of the
chamber.
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Mitochondrial Dehydrogenase Assay
Cell viability of both WT and ucp3/ MEFs was assessed by
measuring the activity of the mitochondrial dehydrogenase
under basal conditions and after 24-hour hypoxia. Cells were
plated onto 12 wells, and then the conversion of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to
formazan was measured by optical density at 490 nm with a
spectrophotometer (SmartSpec Plus; Bio-Rad).
Mitochondrial Aconitase Activity Assay
Changes in mitochondrial aconitase activity were detected
using a BIOXYTECH Aconitase-340 kit (OxisResearch) accord-
ing to the manufacturer’s instructions. Mitochondrial protein
fraction was obtained as previously described.31 Briefly, LV
samples were lysed in a buffer containing mannitol
250 mmol/L, EGTA 0.5 mmol/L, HEPES 5 mmol/L, and
0.1% BSA. Samples were then centrifuged at 1000g for
5 minutes at 4°C to pellet nuclei, membranes, and unbroken
cells. The supernatant was centrifuged at 10 500g for
15 minutes at 4°C to separate the soluble cytosolic fraction
from a pellet containing mitochondria. The pellet was
sonicated and then resuspended in lysis buffer. The enrich-
ment for mitochondria in the membrane fraction and their
absence in the soluble cytosolic fraction were assessed by
immunoblotting for the mitochondrial voltage-dependent
anion channel. Aconitase activity was expressed as microunits
of cis-aconitate converted per minute per milligram of
mitochondrial protein.
Determination of Mitochondrial Respiration
Mitochondrial respiration was measured polarographically by
using a Clark-type oxygen electrode (Rank Brothers) at 25°C
in 0.5 mL of respiratory buffer (KCl 80 mmol/L, HEPES
50 mmol/L, EGTA 1 mmol/L, KH2PO4 5 mmol/L, MgCl2
2 mmol/L, 0.5% BSA, pH 7.0). Respiration was initiated by
adding glutamate 5 mmol/L and malate 2.5 mmol/L as
substrates for complex I or succinate 5 mmol/L (in combi-
nation with rotenone 2 lmol/L to inhibit complex I) as
substrate for complex II. After recording of basal oxygen
consumption, respiration was determined after the addition of
ADP 200 lmol/L (state 3 ADP). State 3 ADP was terminated
by adding the ATP synthase inhibitor oligomycin (1 lg/mL) to
achieve a state 4O rate (to prevent ATP recycling contribution
to the respiration). Complex IV respiration was determined
after the addition of antimycin A 1.8 lmol/L to inhibit
complex II and TMPD (N,N,N0,N0-tetramethyl-p-phenylenedi-
amine) 300 lmol/L and ascorbate 3 mmol/L, which donates
electrons to cytochrome oxidase via the reduction of
cytochrome c.
NAD+/NADH Assay
The total levels of nicotinamide adenine dinucleotide (NADt)
and its reduced form, NADH, were analyzed in cell and heart
lysates using a NAD+/NADH quantification kit (MBL; Interna-
tional Corporation) according to the manufacturer’s instruc-
tions. NADt or NADH levels were expressed in picomoles per
106 cells (in MEFs) or nanograms per milligrams of protein (in
cardiac lysates). NAD/NADH ratio is calculated as NADt
NADH/NADH.
Mitochondrial Membrane Potential Assessment
by Tetramethylrhodamine Ethyl Ester
Mitochondrial membrane potential (Dwm) was assessed by
flow cytometry using tetramethylrhodamine ethyl ester
(TMRE; Molecular Probes), a nontoxic monovalent cation that
reversibly accumulates in the mitochondrial lipid environment
according to membrane potential with a Nernstian distribu-
tion. After specific treatments, cultured WT and ucp3/
MEFs or CMs were resuspended in their complete media and
incubated with TMRE 50 nmol/L for 20 minutes in the dark at
37°C. At the end of incubation, cells were resuspended in the
flow analysis buffer (PBS 19), and kept on ice until analysis.
Mitochondrial ROS Generation
Mitosox Red (Molecular Probes) was used to assess the
generation of mitochondrial superoxide in vivo and in vitro as
previously described.31 Ten micrograms of Mitosox Red in
200 lL of PBS was injected into the tail vein of each mouse.
Animals were killed 90 minutes later, the hearts were rapidly
removed, and the left ventricle was dissected and fixed
overnight in 4% paraformaldehyde, included in optimum
cutting temperature compound (Miles Pharmaceuticals), and
snap frozen in liquid nitrogen. Then, 10-lm LV sections were
cut using a cryostat. In vitro, cultured WT and ucp3/ MEFs
or CMs under normoxic and hypoxic conditions were
incubated with the Mitosox Red reagent for 10 minutes and
then visualized with use of a fluorescent Nikon Eclipse TE
2000-U microscope.
Electron Microscopy
In electron microscopy studies, 6 animals (sham: ucp3/,
n=3; WT, n=3; MI: ucp3/, n=3; WT, n=3) were anaesthe-
tized with an intramuscular injection of ketamine 100 mg/kg
and xylazine 5 mg/kg, and the hearts were fixed by
retrograde aortic perfusion. The hearts were then dissected,
and the LV anterior wall was selected for the detailed
comparative study reported here. Tissue samples were cut
into small blocks and postfixed with the same fixative for
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2 hours and then with 2% osmium tetroxide for 1 hour. They
were embedded in araldite at 60°C. Ultrathin sections
mounted on grids were counterstained with uranyl acetate
and lead citrate.
RNA Extraction and Real-Time PCR
Total RNA was obtained from ventricular specimens and from
MEFs as previously described.31 Oligo-dT first-strand cDNA
synthesis and ucp2 and ucp3 mRNA expression were
determined in cardiac samples and in normoxic/hypoxic
MEFs by real-time quantitative PCR (RT-PCR) using an IQ-5
Multicolor Real-Time PCR Detection System (Bio-Rad).
Protein Extraction and Immunoblot Analysis
Cultured cells and LV samples were lysed, and immunoblot-
ting was performed using commercially available antibodies.
Cultured cells and LV samples were lysed in a buffer
containing NaCl 150 mmol/L, Tris 50 mmol/L (pH 8.5),
EDTA 1 mmol/L, 1% v/v Nonidet P-40, 0.5% w/v deoxych-
olate, NaF 10 mmol/L, Na2 pyrophosphate 10 mmol/L, PMSF
2 mmol/L, leupeptin 2 lg/mL and aprotinin 2 lg/mL.
Lysates were incubated on ice for 15 minutes and then
centrifuged at 38 000g for 30 minutes at 4°C. Protein
concentrations in all lysates were measured using a dye-
binding protein assay kit (Bio-Rad) and a spectrophotometer
reader (Bio-Rad) at a wavelength of 595 nm. Immunoblotting
was performed using the following commercially available
antibodies: cleaved caspase 3 (rabbit monoclonal; Cell
Signaling), phosphorylated-AKT (rabbit polyclonal; Santa Cruz),
p53 (mouse monoclonal; Santa Cruz), UCP2 (goat polyclonal;
Sigma-Aldrich), UCP3 (rabbit polyclonal; Sigma-Aldrich), total
AKT (rabbit polyclonal; Santa Cruz), GAPDH (mouse monoclo-
nal; Upstate Biotechnology), and a-tubulin (mouse monoclo-
nal; Santa Cruz). Secondary antibodies were purchased from
Amersham Life Sciences. Bands were visualized by use of
enhanced chemiluminescence (ECL; Amersham Life Sciences)
according to the manufacturer’s instructions and were
quantified using densitometry (Chemidoc; Bio-Rad). Each
experiment and densitometric quantification was separately
repeated at least 3 times.
Statistical Analysis
Data are expressed as meanSE. Comparisons between 2
groups were performed using the unpaired Student t test. For
MI experiments, comparisons were made by 2-way analysis of
variance (ANOVA) or, when noted, by 1-way ANOVA, and P
values shown indicate the effect of genotype on the MI-
stimulated response. Correction for multiple comparisons was
made using the Student–Newman–Keuls method. A minimum
value of P<0.05 was considered statistically significant. All
the analyses were performed with GraphPad Prism version
5.01.
Results
Increased Oxidative Stress and Mitochondrial
Dysfunction in Primary MEFs and Adult CMs
From ucp3/ or WT Mice
Primary MEFs were isolated from WT and ucp3/ mice to
analyze the effects of ucp3 genetic deletion on mitochondrial
function, ROS production, and cell survival during normoxia or
after 4 hours of hypoxia. Compared with WT, hypoxic ucp3/
MEFs exhibited more pronounced mitochondrial dysfunction,
as shown by a significant reduction in the NAD+/NADH ratio
(Figure 1A) and in mitochondrial membrane potential, mea-
sured as percent reduction of the TMRE fluorescence
(Figure 1B). Mitochondrial dysfunction was also associated
with a significant decrease in mitochondrial dehydrogenase
(MTT) activity in ucp3/ MEFs compared with WT under both
normoxic or hypoxic conditions (Figure 1C) and with a
significant increase in mitochondrial production of ROS, as
shown by Mitosox Red staining (Figure 1D). Mitochondrial
dysfunction and increased ROS production may be responsi-
ble for the significantly increased apoptotic cell death induced
by ischemia in ucp3/ MEFs (Figure 1E). Importantly, these
results were confirmed in primary adult CMs isolated from
ucp3/ or WT mice (Figure 2A through 2C). Taken together,
these results suggest that ucp3 levels regulate mitochondrial
function, ROS production, and, in turn, cell survival under
hypoxic conditions in vitro.
Mitochondria Respiratory Parameters of WT and
ucp3/Mice Are Differently Affected by
Ischemia–Reperfusion
To detect how ucp3 deletion and ischemia–reperfusion might
affect mitochondrial respiratory parameters, oxygen consump-
tion was evaluated in experimental conditions in which
the synthesis and the export of ATP are at maximal rates
(state 3ADP) and when this process is terminated by oligomycin
(state 4O). In addition, we measured the respiratory control
ratio (RCR). Under normoxic conditions, the absence of ucp3
significantly influenced the mitochondrial respiration rate only
when a complex II–linked substrate was used (Figure 2A
through 2C). Indeed, succinate (+rotenone)-energized mito-
chondria from ucp3/ mice showed a significant reduction in
state 4O respiration, whereas no significant differences in state
3ADP respiration values were observed (Figure 3A through 3C).
At the same time, the RCR value was higher in ucp3/ mice
compared with WT mice (Figure 3A through 3C).
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In mitochondria from WT mice, ischemia–reperfusion
induced an increase in state 4 respiration and a decrease in
RCR values, index of mitochondrial uncoupling, when using
glutamate+malate and succinate+rotenone as substrates.
Interestingly, while ischemia and reperfusion affected mito-
chondrial parameters in WT mice, it did not affect them in
mitochondria from knockout mice (Figure 3A through 3C).
Finally, the absence of neither ucp3 nor ischemia–reperfusion
affected mitochondria respiratory parameters detected using a
complex IV–linked substrate, since no significant differences in
state 3ADP, state 4O, and RCR were observed in any considered
group. Taken together, these data confirm that ischemia–
reperfusion induces mitochondrial uncoupling, as already
reported in the literature,35 and suggest that ucp3 might be
involved in ischemia–reperfusion–induced uncoupling.
Myocardial Infarct Size Is Increased in ucp3/
Mice After Permanent Coronary Ligation
To test whether ucp3 genetic deletion might affect cardiac
responses to ischemia in vivo, MI was induced by permanent
coronary artery ligation in WT and ucp3/ mice as previously
described.28 Sham-operated animals from both genotypes
underwent the same surgical procedure without occlusion of
Figure 1. The ucp3 genetic deletion impairs mitochondrial activity, increases ROS production, and promotes cell death in MEFs. A, NAD+/NADH
ratio in wild-type (WT) and ucp3/ MEFs under normoxic or hypoxic conditions (*P<0.05 for 2-way ANOVA test comparing normoxia and hypoxia
of different genotype; *P<0.05 vs normoxia, WT hypoxia ). B, Mitochondrial membrane potential assessed by TMRE in WT and ucp3/ MEFs
under normoxic or hypoxic conditions (*P<0.05 and **P<0.05 for 2-way ANOVA test comparing normoxia and hypoxia of different genotypes;
*P<0.05 vs normoxia; **P<0.05 vs normoxia, WT hypoxia). C, Bar graphs showing the conversion of yellow MTT to purple formazan in the
mitochondria of WT and ucp3/ MEFs under normoxic or hypoxic conditions (*P<0.05 and **P<0.05 for 2-way ANOVA test comparing normoxia
and hypoxia of different genotype; *P<0.05 vs normoxia; **P<0.05 vs normoxia, WT hypoxia). D, Top: Representative images illustrating
mitochondrial ROS production in MEFs from WT and ucp3/ mice under normoxic or hypoxic conditions. Scale bar=10 lm. Bottom: Cumulative
data of multiple independent experiments (*P<0.05 and **P<0.05 for 2-way ANOVA test comparing normoxia and hypoxia of different genotypes;
*P<0.05 vs normoxia; **P<0.05 vs normoxia, WT hypoxia). E, Top: Representative DAPI and TUNEL staining in MEFs from WT and ucp3/ mice
under normoxic or hypoxic conditions. Positive nuclei appear green (arrowheads). Bottom: Cumulative data of multiple independent experiments
(*P<0.05 and **P<0.05 for 2-way ANOVA test comparing normoxia and hypoxia of different genotype; *P<0.05 vs normoxia; **P<0.05 vs
normoxia, WT hypoxia). Scale bar=250 lm. ucp3 indicates uncoupling protein 3; ROS, reactive oxygen species; MEFs, mouse embryonic
fibroblasts; WT, wild-type; ANOVA, analysis of variance; TMRE, tetramethylrhodamine ethyl ester; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide; DAPI, 4′-6-diamidino-2-phenylindole; TUNEL, terminal deoxynucleotidyl transferase-dUTP nick end labeling.
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the coronary artery. Because ucp3 levels regulate cell survival
under hypoxic conditions in vitro, studies were performed to
determine whether ucp3 levels might affect the mean infarct
size after permanent coronary artery ligation. Twenty-four
hours after permanent coronary artery ligation, hearts were
infused with Evans blue to demarcate the ischemic area
susceptible to infarction (AAR), and counterstained with
triphenyltetrazolium chloride to identify the final IA from the
viable myocardium within the AAR. Despite similar AARs
between the 2 groups (Table 1), ucp3/ hearts demon-
strated a significantly larger proportion of infarct myocardium
within the AAR compared with WT mice (Figure 4A and
Table 1). Interestingly, treatment with the antioxidant a-
tocopherol significantly reduced the infarct size in ucp3/
mice but did not exert any effects in WT MI mice (Figure 3A
and Table 1), suggesting that increased ROS production might
be responsible for the larger IAs in ucp3/ hearts.
Eight weeks after MI, ucp3/ hearts still displayed a
significantly larger infarct size by positron emission tomog-
raphy imaging (Figure 4B) and Masson’s trichrome staining
(Figure 4C). To rule out abnormal vascular density as the
cause of increased infarct size in ucp3/ mice, histological
studies were performed to determine capillary density in WT
and ucp3/ hearts before and after MI. WT and ucp3/
mice displayed similar capillary densities under basal
conditions and, after 8 weeks MI, in the peri-IA (Figure 4D
and 4E). Interestingly, ucp3/ mice showed a significant
decrease of the capillary density in the remote area after
8 weeks of MI compared with WT mice (Figure 4D and 4E).
Genetic Deletion of the ucp3 Gene Reduces
Survival and Cardiac Function After Acute MI
Infarct size is one of the major determinants of postischemic
cardiac remodeling. To evaluate cardiac function in WT and
ucp3/ mice after MI, transthoracic echocardiography was
performed in all experimental groups before and 8 weeks
after MI. Under basal conditions, ucp3/ mice displayed
normal cardiac dimensions and function (Figure 5A and 5B
and Table 2). As expected, both WT and ucp3/ mice
developed cardiac dysfunction after MI (Figure 5A and 5B and
Table 2). However, compared with WT, ucp3/ mice
displayed a significant worsening in cardiac function after
coronary artery ligation and a more pronounced increase in
the LV weight–to–body weight ratio at study termination
(Figure 5C and Table 2).
To assess whether these differences would translate into a
survival benefit, survival rates were monitored for 30 days in
all the groups after the surgery. As expected, survival of the
sham 8-week groups was 100% (Figure 5D), whereas MI
resulted in a significantly lower survival in both genotypes
compared with the respective sham 8-week group (P<0.05).
Figure 2. The ucp3 deletion impairs mitochondrial activity, increases reactive oxygen species (ROS) production, and promotes cell death in
adult (CMs). A, Mitochondrial membrane potential assessed by TMRE in WT and ucp3/ CMs under normoxic or hypoxic conditions (*P<0.05
and **P<0.05 for 2-way ANOVA test comparing normoxia and hypoxia of different genotype; *P<0.05 vs normoxia; **P<0.05 vs normoxia, WT
hypoxia). B, Top representative images illustrating mitochondrial ROS production in CMs from WT and ucp3/ mice under normoxic or hypoxic
conditions. Scale bar=10 lm. Bottom cumulative data of multiple independent experiments (*P<0.05 and **P<0.05 for 2-way ANOVA test
comparing normoxia and hypoxia of different genotype; *P<0.05 vs normoxia; **P<0.05 vs normoxia, WT hypoxia). Scale bar=250 lm. C.
Cumulative data of multiple independent experiments to evaluate TUNEL staining in CMs from WT and ucp3/ mice under normoxic or hypoxic
conditions (*P<0.05 and **P<0.05 for 2-way ANOVA test comparing normoxia and hypoxia of different genotype; *P<0.05 vs normoxia;
**P<0.05 vs normoxia, WT hypoxia). ucp3 indicates uncoupling protein 3; CM, cardiomyocyte; WT, wild-type; ANOVA, analysis of variance; TMRE,
tetramethylrhodamine ethyl ester.
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Figure 3. The ucp3 genetic deletion affects mitochondria respiratory parameters in ischemic–reperfused hearts. A, Complex I linked substrate
for mitochondrial state 3 (excess ADP, pyruvate, and malate), state 4 (oligomycin-treated) respiration (nAtO2/mg prot./min) and respiratory
control ratio (RCR=state 3/state 4) of ucp3/ and WT hearts (n=6 mice for group, *P<0.05 for unpaired Student t test comparing SHAM and I/R
of different genotype; *P<0.05 vs SHAM WT). B, Complex II linked substrate for mitochondrial state 3 (excess ADP, pyruvate, and malate), state 4
(oligomycin-treated) respiration (nAtO2/mg prot./min) and respiratory control ratio (RCR=state 3/state 4) of ucp3
/ and WT hearts (n=6 mice
for group, *P<0.05 and #P<0.05 for unpaired Student t test comparing SHAM and I/R of different genotype; *P<0.05 vs SHAM WT, #P<0.05 vs I/
R WT). C, Complex IV linked substrate for mitochondrial state 3 (excess ADP, pyruvate, and malate), state 4 (oligomycin-treated) respiration
(nAtO2/mg prot./min) and respiratory control ratio (RCR=state 3/state 4) of ucp3
/ and WT hearts (n=6 mice for group, not significant). ucp3
indicates uncoupling protein 3; I/R, ischemia–reperfusion; WT, wild-type; SHAM, sham-operated control animals.
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However, the 30-day survival of ucp3/ MI mice was
significantly lower compared with WT MI mice (56 versus 85,
respectively; P<0.05; Figure 5D).
ucp3 Genetic Deletion Promotes Mitochondrial
Dysfunction and Exaggerates Mitochondrial ROS
Production After Coronary Artery Ligation
To analyze the effects of ucp3 genetic deletion on mitochon-
drial structure and function, electron microscopy studies were
performed on WT and ucp3/ MI hearts. Interestingly, under





(n=7) WT (n=5) ucp3/ (n=4)
IA/AAR, % 48.23.7 65.02.9* 46.43.7 47.02.0
AAR/LV, % 35.11.2 29.63.3 28.93.9 31.35.4
MI indicates myocardial infarction; WT, wild-type; ucp3, uncoupling protein 3; IA, infarct
area; AAR, area at risk; LV, left ventricle area.
*P<0.05 vs WT MI+vehicle.
Figure 4. The ucp3 genetic deletion increases infarct size after MI. A, Left: Representative images of TTC staining of heart sections from
WT+vehicle, ucp3/+vehicle, WT+a-tocopherol, and ucp3/+a-tocopherol mice after MI. Right: Bar graphs showing ratios of myocardial infarct
area vs area at risk (IA/AAR) in both groups (*P<0.05 for 2-way ANOVA test comparing vehicle and a-tocopherol of different genotype; *P<0.05
vs all, n=7 for MI+vehicle and n=4 for MI+a-tocopherol). B, Left: Representative positron emission tomography with 2-deoxy-2[18F]fluoro-D-
glucose (18F-FDG PET) horizontal long-axis slice from anterior to inferior wall, long-axis slice from apex to base, and short-axis slice from anterior
to inferior wall from WT and ucp3/ mice after MI. Right: Quantitative analysis of infarct size defined as the proportion of myocardial contour
area of infarcted myocardium, derived by PET (*P<0.05 for unpaired Student t test comparing MI of different genotype; *P<0.05 vs WT n=14
hearts/group). C, Left: Representative images of Masson’s trichrome staining of heart sections from WT and ucp3/ mice after MI. Right: Bar
graphs showing percent infarct size (*P<0.05 for unpaired Student t test comparing MI of different genotype; *P<0.05 vs WT n=10 hearts/group).
D, Representative lectin staining in cardiac sections from WT SHAM (n=4), ucp3/ SHAM (n=4), WT MI (n=6), ucp3/ MI (n=6) mice. Peri-
infarct area and remote area are shown. Capillaries appear brown (9600 magnification). E, Cumulative data of multiple independent experiments
analyzing capillarity density (*P<0.05 for 2-way ANOVA test comparing MI peri-infarct area to SHAM; **P<0.05 for 2-way ANOVA test comparing
MI remote area to MI peri-infarct area; §P<0.05 for 2-way ANOVA comparing ucp3/ MI remote area to WT MI remote area; *P<0.05 vs SHAM;
**P<0.05 vs MI peri-infarct area; §P<0.05 vs WT MI remote area). ucp3 indicates uncoupling protein 3; WT, wild-type; MI, myocardial infarction;
TTC, triphenyltetrazolium chloride; ANOVA, analysis of variance; PET, positron emission tomography; SHAM, sham-operated control animals.
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Figure 5. ucp3 genetic deletion promotes cardiac dysfunction and reduces survival after MI. A, Representative M-mode echocardiographic
tracings from WT and ucp3/ mice after 8 weeks MI or SHAM procedure. B, Cumulative data of % fractional shortening (FS) of WT and ucp3/
mice 8 weeks after MI (*P<0.05 and **P<0.05 for 2-way ANOVA test comparing SHAM and MI of different genotype; *P<0.05 vs SHAM;
**P<0.05 vs SHAM, WT MI n=10 hearts/group). C, Bar graphs showing left ventricle weight/body weight (LVW/BW) ratios in WT and ucp3/
mice after MI or SHAM procedure (*P<0.05 and **P<0.05 for 2-way ANOVA test comparing SHAM and MI of different genotype; *P<0.05 vs
SHAM; **P<0.05 vs SHAM, WT MI n=10 hearts/group). D, Kaplan–Meier cumulative survival analysis of WT and ucp3/ mice after MI (WT:
SHAM, n=11, MI, n=28; ucp3/: SHAM, n=12, MI, n=30; *P<0.001 and **P<0.001 comparing MI to SHAM of different genotype, *P<0.001 vs
SHAM, ** P<0.001 vs SHAM, WT MI). ucp3 indicates uncoupling protein 3; WT, wild-type; MI, myocardial infarction; ANOVA, analysis of variance;
SHAM, sham-operated control animals.
Table 2. Morphometric and Echocardiographic Parameters After 8 Weeks of MI or Sham Operation in WT and ucp3/ Mice
SHAM 8 Weeks MI 8 Weeks
WT (n=11) ucp3/ (n=12) WT (n=30) ucp3/ (n=28)
Morphometry
BW, g 260.9 25.80.8 260.2 25.30.4
LVW, mg 985.4 100.11.1 138.213.5* 160.812.8†
LVW/BW, mg/g 3.70.6 3.80.47 5.51.0* 6.81.0†
Echocardiography
LVEDD, mm 3.40.03 3.40.06 4.10.8* 5.10.04*
LVESD, mm 1.60.02 1.40.03 2.40.2* 3.80.05†
FS, % 54.00.02 58.80.02 42.70.03* 24.40.05†
IVSd, mm 0.90.08 0.80.12 1.10.10 1.010.05
PWd, mm 0.90.08 0.930.12 0.80.10 0.90.05
HR, bpm 45724 46915 48620 47922
MI indicates myocardial infarction; SHAM, sham-operated control animals; WT, wild-type; ucp3, uncoupling protein 3; BW, body weight; LVW, left ventricular weight; LVEDD, left ventricular
end-diastolic diameter; LVESD, left ventricular end-systolic diameter; FS, fractional shortening; IVSd, end-diastolic interventricular septum; PWd, end-diastolic posterior wall; HR, heart rate.
*P<0.05 vs SHAM.
†P<0.05 vs SHAM and WT MI.
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basal conditions, mitochondria of both WT and ucp3/ CMs
were morphologically normal (Figure 6). After MI, mitochon-
dria of WT CMs were dilated with well-defined lamellar cristae
and clear matrix (Figure 5). Conversely, after coronary ligation
in ucp3/ mice, a dense mitochondrial matrix could be
observed within the dilated cristae (Figure 6). Moreover, in
ucp3/ MI hearts, diverticula-like protrusions could be seen
from the mitochondrial wall, suggesting the occurrence of
organelle fragmentation that ultimately could justify the
apparent increase in number of small mitochondria (Figure 6).
These morphological abnormalities were associated with
reduced mitochondrial aconitase activity and NAD+/NADH
ratio in ucp3/ MI hearts compared with WT MI hearts
(Figure 7A and 7B), whereas mitochondrial ROS generation
was significantly increased (Figure 7C).
Increased Apoptotic Cell Death in ucp3/
Hearts After Coronary Artery Ligation
To determine whether mitochondrial dysfunction in ucp3/
mice would increase apoptotic cell death after MI, TUNEL
staining was performed in cardiac sections from the different
groups. As shown in Figure 8A, ucp3 genetic deletion
significantly increased the rate of apoptotic cell death
8 weeks after MI. Consistent with these results, cleaved
caspase 3 and p53 levels were significantly higher in ucp3/
hearts after MI, whereas AKT phosphorylation was signifi-
cantly reduced (Figure 8B through 8D). Taken together, these
data suggest that ucp3 levels regulate cell survival and infarct
size after acute MI by modulating mitochondrial structural and
functional adaptations to myocardial ischemia.
Discussion
The present study shows that mitochondrial ucp3 plays a
pivotal role in the regulation of mitochondrial function, ROS
production, and cell survival in the ischemic heart, modulating
infarct size, cardiac remodeling, and survival after MI. These
beneficial effects could be related to the ability of ucp3 to
promote mitochondrial uncoupling and control ROS production
and suggest that uncoupling proteins might represent novel
therapeutic targets in patients with coronary artery disease.
In patients with an acute ischemic event, the prognosis is
mainly dependent on the amount of myocardium that is lost.36
Thus, during the past 40 years, there has been an intense
effort to identify cardioprotective therapies to limit infarct size
and ameliorate cardiac remodeling.37,38 There is no definitive
evidence that antioxidants exert a beneficial effect on
postischemic cardiac remodeling in clinical trials,9 and it is
possible that clinically available drugs are insufficient in their
potency, the dose of the drug is not optimal, or the timing of
administration is not appropriate.
The family of mitochondrial uncoupling proteins has been
recently recognized as being important in the regulation of
mitochondrial function and ROS production.39 In the mam-
malian heart, ucp2 and ucp3 are the predominant ucp
isoforms,16 and there is substantial literature supporting the
protective effect of these ucps in ischemia–reperfusion
injury.40,41 Indeed, overexpression of UCPs decreases ROS
production, improves CM survival and contractile function in
the setting of ischemia–reperfusion. However, the effects of
ucp3 deletion under conditions of chronic HF induced by
permanent coronary artery ligation have never been tested.
Figure 6. ucp3 genetic deletion promotes cardiac mitochondria
morphological changes. Representative electron microscopy micro-
photographs of cardiac sections from WT and ucp3/hearts after
SHAM or MI procedure (93000,97000, and912 500 magnification;
n=6 hearts/group). ucp3 indicates uncoupling protein 3;WT, wild-type;
MI, myocardial infarction; SHAM, sham-operated control animals.
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Importantly, while a decrease in ucp3 expression would be
expected to enhance the energetic efficiency in stressed
CMs, it might also have the counterbalancing effect of
allowing greater production of ROS. Thus, the question
remains of whether ucp3 downregulation in chronic HF is
maladaptive.
Our study shows that ucp3 deletion tends to increase
oxidative phosphorylation efficiency, since higher RCR
values were observed in ucp3/ mice compared with
WT mice. In addition, results indicate that ucp3 is possibly
involved in ischemia–reperfusion–induced uncoupling. In
fact, the increase of mitochondrial respiration principally
controlled by the activity of the proton leak (state 4O) and
the decrease in RCR are observed solely in mitochondria
from WT mice.
After ischemia–reperfusion, the activation of UCP3-medi-
ated-uncoupling could be considered as a mechanism of
protection against ROS damage. This concept is in line with
data indicating that the administration of low concentrations
of uncoupling agents, such as carbonyl cyanide p-(trifluoro-
methoxy)phenylhydrazone (FCCP) or 2,4-dinitrophenol,
evokes protection against ischemic damage in the intact
heart,42 in CMs,43 and in the brain,44 in parallel with a
diminution in mitochondrial ROS production. Consistent with
this assumption, our study shows that ucp3 expression levels
modulate cell survival under low oxygen conditions in vitro
and in vivo, because ucp3 genetic deletion exaggerated
hypoxia or ischemia-induced apoptotic cell death.
Interestingly, ucp3/ hearts displayed increased levels of
oxidative damage markers and decreased activity of
Figure 7. ucp3 genetic deletion promotes mitochondrial dysfunction in vivo. A, Mitochondrial aconitase activity in WT and ucp3/ hearts after
MI (*P<0.05 and **P<0.05 for 2-way ANOVA test comparing SHAM and MI of different genotype; *P<0.05 vs SHAM; **P<0.05 vs SHAM, WT MI
n=5 hearts/group). B, NAD+/NADH ratio in WT and ucp3/ hearts after SHAM or MI procedure (*P<0.05 and **P<0.05 for 2-way ANOVA test
comparing SHAM and MI of different genotype; *P<0.05 vs SHAM; **P<0.05 vs SHAM, WT MI n=5 hearts/group). C, Left: Representative Mitosox
staining of cardiac sections of WT and ucp3/ hearts after MI (9200 magnification). Right: Cumulative data of Mitosox fluorescence from
independent experiments (*P<0.05 and **P<0.05 for 2-way ANOVA test comparing SHAM and MI of different genotype; *P<0.05 vs SHAM;
**P<0.05 vs SHAM, WT MI n=5 hearts/group). ucp3 indicates uncoupling protein 3; WT, wild-type; MI, myocardial infarction; ANOVA, analysis of
variance; SHAM, sham-operated control animals.
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aconitase, a protein sensitive to damage by superoxide.45 In
ucp3/ hearts, such abnormalities were associated with
larger IAs after permanent coronary artery occlusion, adverse
remodeling, and reduced survival. Importantly, in vivo treat-
ment with the antioxidant a-tocopherol reduced the infarct
size in ucp3/ mice to WT values, suggesting that ucp3
Figure 8. ucp3 genetic deletion and cardiomyocyte death in vivo. A, Top: Representative DAPI (left) and TUNEL staining (right) in cardiac
sections of WT and ucp3/ hearts after 8 weeks MI. Positive nuclei appear green (arrowheads). Bottom: Cumulative data of multiple
independent experiments (*P<0.05 and **P<0.05 for 2-way ANOVA test comparing SHAM and MI of different genotypes; *P<0.05 vs SHAM;
**P<0.05 vs SHAM, WT MI n=5 hearts/group). Scale bar=250 lm. Representative immunoblot (IB) (top) and densitometric analysis (bottom) of 4
independent experiments to evaluate cleaved caspase 3 (B), p53 (C), and phosphorylated-AKT (D) protein levels in WT and ucp3/ hearts after
MI (for all, *P<0.05 and **P<0.05 for 2-way ANOVA test comparing SHAM and MI of different genotypes; *P<0.05 vs SHAM; **P<0.05 vs SHAM,
WT MI n=5 hearts/group). ucp3 indicates uncoupling protein 3; WT, wild-type; MI, myocardial infarction; DAPI, 4′-6-diamidino-2-phenylindole;
ANOVA, analysis of variance; SHAM, sham-operated control animals.
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Figure 9. UCP2 and UCP3 levels in hearts and MEFs from WT and ucp3/ mice. A, ucp3 mRNA levels in WT and ucp3/ hearts after 8 weeks
of myocardial infarction (*P<0.05 for unpaired Student t test comparing MI to SHAM; n=5 hearts/group). B, Representative immunoblot (IB) and
densitometric analysis of 4 independent experiments to evaluate ucp3 protein levels in WT hearts after 8 weeks of myocardial infarction (*P<0.05
for unpaired Student t test comparing MI to SHAM; n=5 hearts/group). C, ucp2 mRNA levels in WT and ucp3/ hearts after 8 weeks of
myocardial infarction (*P<0.05 for 2-way ANOVA test comparing SHAM and MI of different genotype; *P<0.05 vs SHAM n=5 hearts/group). D,
Representative IB and densitometric analysis of 4 independent experiments to evaluate ucp2 protein levels in WT and ucp3/ hearts after
8 weeks of myocardial infarction (*P<0.05 for 2-way ANOVA test comparing SHAM and MI of different genotype; *P<0.05 vs SHAM n=5 hearts/
group). E, ucp2 mRNA levels in WT and ucp3/ MEFs during normoxic and hypoxic conditions (*P<0.05 for 2-way ANOVA test comparing
normoxia and hypoxia of different genotype; *P<0.05 vs normoxia). F, Representative IB and densitometric analysis of 4 independent experiments
to evaluate ucp2 protein levels in WT and ucp3/ MEFs during normoxic and hypoxic conditions (*P<0.05 for 2-way ANOVA test comparing
normoxia and hypoxia of different genotypes; *P<0.05 vs normoxia). ucp indicates uncoupling protein; MEFs, murine embryonic fibroblasts;
WT, wild-type; MI, myocardial infarction; ANOVA, analysis of variance; SHAM, sham-operated control animals.
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deletion may enhance cell death in response to hypoxia by
increasing ROS production over WT levels. However, unlike
2,4-dinitrophenol,42 a-tocopherol did not reduce the infarct
size in WT mice, confirming results from clinical trials showing
that inhibition of endogenous ROS levels is not sufficient to
prevent cell death induced by myocardial ischemia9 and
suggesting that other mechanisms triggered by mitochondrial
uncoupling might regulate CM survival under low oxygen
conditions. Indeed, in addition to the regulation of ROS
production, it has been suggested that ucp2 and/or ucp3
proteins are essential components of the mitochondrial
calcium uptake pathway,46 because overexpression of these
proteins enhanced the transfer of cytosolic calcium signals to
the mitochondria, which could also protect the cells from
oxidative stress.46 However, this possible novel function of
ucp2 and ucp3 has been subsequently challenged.47 Indeed,
recent results indicate that ucp3 is not a mitochondrial Ca2+
uniporter and that it negatively modulates the activity of
sarcoplasmic/endoplasmic reticulum Ca2+ pumps by limiting
mitochondrial ATP production.48 Thus, the effects of ucp3 on
mitochondrial Ca2+ seem to merely reflect metabolic altera-
tions that have an impact on cellular Ca2+ homeostasis.
After 8 weeks of MI, ucp3/ hearts were also characterized
by reduced capillary density in the remote peri-IA of the left
ventricle. These data suggest that ucp3 deletion might exert
detrimental effects on cardiac function and remodeling of the
ischemic heart via other mechanisms, eventually acting in
surviving cells, including vascular rarefaction.25,49 Importantly,
MI hearts from ucp3/ mice were characterized by structural
and functional mitochondrial abnormalities and increased mito-
chondrial ROS production despite a normal induction of ucp2
mRNA/protein levels in vitro and in vivo (Figure 9A through 9F).
In addition to hemodynamic alterations and HF,50 doxoru-
bicin treatment has been shown to decrease ucps expres-
sion.51,52 Thus, although our study focused on the role of
ucp3 during conditions of myocardial ischemia, it is also
possible that this protein might be involved in the pathogen-
esis of different pathological cardiac conditions, such as those
induced by cardiotoxic chemotherapy drugs.
In conclusion, our study indicates a role for ucp3 in
ischemic failing murine heart. The ucp3 genetic deletion
promotes mitochondrial dysfunction, and increases ROS
production and apoptotic cell death under low oxygen
conditions, enlarging infarct size and accelerating HF. These
results suggest that ucp3 levels might represent a novel
determinant of postischemic cardiac remodeling and survival.
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